These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 4019928

  • 1. Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy.
    Rae AP, Sokoloff NM, Webb CR, Spielman SR, Greenspan AM, Horowitz LN.
    J Am Coll Cardiol; 1985 Aug; 6(2):410-6. PubMed ID: 4019928
    [Abstract] [Full Text] [Related]

  • 2. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
    Rae AP, Spielman SR, Kutalek SP, Kay HR, Horowitz LN.
    Am J Cardiol; 1987 Feb 01; 59(4):291-5. PubMed ID: 3544793
    [Abstract] [Full Text] [Related]

  • 3. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
    Waxman HL, Buxton AE, Sadowski LM, Josephson ME.
    Circulation; 1983 Jan 01; 67(1):30-7. PubMed ID: 6847803
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
    Greenspan AM, Spielman SR, Webb CR, Sokoloff NM, Rae AP, Horowitz LN.
    Am J Cardiol; 1985 Aug 01; 56(4):277-84. PubMed ID: 4025166
    [Abstract] [Full Text] [Related]

  • 6. Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardia.
    Gold RL, Haffajee CI, Alpert JS.
    Am Heart J; 1986 Jul 01; 112(1):9-13. PubMed ID: 3728294
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
    Whitford EG, McGovern B, Schoenfeld MH, Garan H, Newell JB, McElroy M, Ruskin JN.
    Am Heart J; 1988 Feb 01; 115(2):360-6. PubMed ID: 3341170
    [Abstract] [Full Text] [Related]

  • 9. Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias.
    Greenspan AM, Spielman SR, Horowitz LN.
    Pacing Clin Electrophysiol; 1986 Jul 01; 9(4):565-76. PubMed ID: 2426675
    [Abstract] [Full Text] [Related]

  • 10. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
    Horowitz LN, Josephson ME, Farshidi A, Spielman SR, Michelson EL, Greenspan AM.
    Circulation; 1978 Dec 01; 58(6):986-97. PubMed ID: 709782
    [Abstract] [Full Text] [Related]

  • 11. Proarrhythmic effects of antiarrhythmic drugs during programmed ventricular stimulation in patients without ventricular tachycardia.
    Au PK, Bhandari AK, Bream R, Schreck D, Siddiqi R, Rahimtoola SH.
    J Am Coll Cardiol; 1987 Feb 01; 9(2):389-97. PubMed ID: 2433319
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prediction of successful suppression of sustained ventricular tachyarrhythmias by serial drug testing from data derived at the initial electrophysiologic study.
    Kuchar DL, Rottman J, Berger E, Freeman CS, Garan H, Ruskin JN.
    J Am Coll Cardiol; 1988 Oct 01; 12(4):982-8. PubMed ID: 3047198
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia.
    Dorian P, Newman D, Berman N, Hardy J, Mitchell J.
    J Am Coll Cardiol; 1993 Jul 01; 22(1):106-13. PubMed ID: 8509529
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide.
    Karagueuzian HS, Sugi K, Ohta M, Meesmann M, Ino T, Peter T, Mandel WJ.
    Am Heart J; 1986 Dec 01; 112(6):1173-83. PubMed ID: 3788764
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia.
    Rials SJ, Britchkow D, Marinchak RA, Kowey PR.
    Clin Cardiol; 2000 Mar 01; 23(3):171-4. PubMed ID: 10761804
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.